| |
| |
|
| Insider
Information: |
Graham Richard A |
| Relationship: |
|
| City: |
South San Francisco |
| State: |
CA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
1 |
|
| Direct
Shares |
314,915 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$2,872,025 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
314,915 |
|
|
| Total
Value |
$2,872,025 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
|
|
| Stock
price went down : |
|
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Theravance Biopharma, Inc. |
TBPH |
|
2024-02-20 |
314,915 |
|
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
25 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| TBPH |
Theravance Biopharma, Inc... |
SVP, RESEARCH & DEVELOPMENT |
• – – |
2024-02-20 |
4 |
D |
$8.92 |
$172,102 |
D/D |
(19,294) |
314,915 |
0 |
- |
|
| TBPH |
Theravance Biopharma, Inc... |
SVP, RESEARCH & DEVELOPMENT |
• – – |
2023-11-20 |
4 |
D |
$10.37 |
$130,973 |
D/D |
(12,630) |
334,209 |
0 |
- |
|
| TBPH |
Theravance Biopharma, Inc... |
SVP, RESEARCH & DEVELOPMENT |
• – – |
2023-11-14 |
4 |
AS |
$10.22 |
$25,366 |
D/D |
(2,482) |
346,839 |
0 |
% |
|
| TBPH |
Theravance Biopharma, Inc... |
SVP, RESEARCH & DEVELOPMENT |
• – – |
2023-10-30 |
4 |
A |
$0.00 |
$0 |
D/D |
15,000 |
349,321 |
0 |
- |
|
| TBPH |
Theravance Biopharma, Inc... |
SVP, RESEARCH & DEVELOPMENT |
• – – |
2023-10-16 |
4 |
AS |
$9.03 |
$22,412 |
D/D |
(2,482) |
334,321 |
0 |
% |
|
| TBPH |
Theravance Biopharma, Inc... |
SVP, RESEARCH & DEVELOPMENT |
• – – |
2023-09-14 |
4 |
AS |
$9.89 |
$24,547 |
D/D |
(2,482) |
336,803 |
0 |
% |
|
| TBPH |
Theravance Biopharma, Inc... |
SVP, RESEARCH & DEVELOPMENT |
• – – |
2023-08-20 |
4 |
D |
$9.70 |
$101,472 |
D/D |
(10,461) |
339,285 |
0 |
- |
|
| TBPH |
Theravance Biopharma, Inc... |
SVP, RESEARCH & DEVELOPMENT |
• – – |
2023-08-11 |
4 |
AS |
$9.99 |
$23,197 |
D/D |
(2,322) |
349,746 |
0 |
% |
|
| TBPH |
Theravance Biopharma, Inc... |
SVP, RESEARCH & DEVELOPMENT |
• – – |
2023-07-14 |
4 |
AS |
$9.84 |
$22,848 |
D/D |
(2,322) |
352,068 |
0 |
% |
|
| TBPH |
Theravance Biopharma, Inc... |
SVP, RESEARCH & DEVELOPMENT |
• – – |
2023-06-14 |
4 |
AS |
$10.69 |
$24,822 |
D/D |
(2,322) |
354,390 |
0 |
% |
|
| TBPH |
Theravance Biopharma, Inc... |
SVP, RESEARCH & DEVELOPMENT |
• – – |
2023-05-20 |
4 |
D |
$11.21 |
$117,257 |
D/D |
(10,460) |
356,712 |
0 |
- |
|
| TBPH |
Theravance Biopharma, Inc... |
SVP, RESEARCH & DEVELOPMENT |
• – – |
2023-05-15 |
4 |
AS |
$11.26 |
$26,146 |
D/D |
(2,322) |
367,172 |
0 |
% |
|
| TBPH |
Theravance Biopharma, Inc... |
SVP, RESEARCH & DEVELOPMENT |
• – – |
2023-04-14 |
4 |
AS |
$11.88 |
$27,597 |
D/D |
(2,323) |
369,494 |
0 |
% |
|
| TBPH |
Theravance Biopharma, Inc... |
SVP, RESEARCH & DEVELOPMENT |
• – – |
2023-03-14 |
4 |
AS |
$10.32 |
$23,973 |
D/D |
(2,323) |
371,817 |
0 |
% |
|
| TBPH |
Theravance Biopharma, Inc... |
SVP, RESEARCH & DEVELOPMENT |
• – – |
2023-03-06 |
4 |
AS |
$10.05 |
$23,346 |
D/D |
(2,323) |
374,140 |
0 |
% |
|
| TBPH |
Theravance Biopharma, Inc... |
SVP, RESEARCH & DEVELOPMENT |
• – – |
2023-03-01 |
4 |
A |
$0.00 |
$0 |
D/D |
75,000 |
376,463 |
0 |
- |
|
| TBPH |
Theravance Biopharma, Inc... |
SVP, RESEARCH & DEVELOPMENT |
• – – |
2023-02-20 |
4 |
D |
$10.44 |
$125,875 |
D/D |
(12,057) |
301,463 |
0 |
- |
|
| TBPH |
Theravance Biopharma, Inc... |
SVP, RESEARCH & DEVELOPMENT |
• – – |
2022-12-01 |
4 |
S |
$10.73 |
$22,361 |
D/D |
(2,084) |
313,520 |
0 |
% |
|
| TBPH |
Theravance Biopharma, Inc... |
SVP, RESEARCH & DEVELOPMENT |
• – – |
2022-11-20 |
4 |
D |
$10.85 |
$296,748 |
D/D |
(27,350) |
315,604 |
0 |
- |
|
| TBPH |
Theravance Biopharma, Inc... |
SVP, RESEARCH & DEVELOPMENT |
• – – |
2022-11-16 |
4 |
D |
$11.20 |
$31,360 |
D/D |
(2,800) |
342,954 |
0 |
- |
|
| TBPH |
Theravance Biopharma, Inc... |
SVP, DEVELOPMENT |
• – – |
2022-08-19 |
4 |
D |
$9.34 |
$177,376 |
D/D |
(18,991) |
345,754 |
0 |
- |
|
| TBPH |
Theravance Biopharma, Inc... |
SVP, DEVELOPMENT |
• – – |
2022-08-16 |
4 |
S |
$9.71 |
$47,640 |
D/D |
(4,906) |
364,745 |
0 |
% |
|
| TBPH |
Theravance Biopharma, Inc... |
SVP, DEVELOPMENT |
• – – |
2022-08-09 |
4 |
S |
$8.79 |
$132,606 |
D/D |
(15,086) |
369,651 |
0 |
% |
|
| TBPH |
Theravance Biopharma, Inc... |
SVP, DEVELOPMENT |
• – – |
2022-05-20 |
4 |
D |
$8.74 |
$34,497 |
D/D |
(3,947) |
384,737 |
0 |
- |
|
| TBPH |
Theravance Biopharma, Inc... |
SVP, DEVELOPMENT |
• – – |
2022-02-18 |
4 |
D |
$9.61 |
$195,823 |
D/D |
(20,377) |
388,684 |
0 |
- |
|
25 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
